EuroPCR 2021 | EBC MAIN: Provisional Stenting vs. Systematic Dual Stenting in Left Main Coronary Artery

Treating the left main coronary artery with provisional stenting was non-inferior to systematic dual stenting in the EBC MAIN trial, presented at EuroPCR 2021 and simultaneously published in the European Heart Journal.

stent provisional vs 2 stents sistemáticos en el tronco

The composite primary endpoint of death, infarction, and target-lesion revascularization was 14.7% for provisional stenting vs. 17.7% for systematic dual stenting (hazard ratio: 0.78; 95% confidence interval: 0.5-1.3).

This discussion of strategies for treating the left coronary artery has been going on for several years and there seems to be no end in sight.

Some studies, such as NORDIC, suggest a higher mortality with dual stenting, while others, like randomized trial DKCRUSH-V, show the opposite.

DKCRUSH-V was the study on which the 2018 European guidelines based their recommendation of the double kissing crush technique over provisional stenting to treat left main artery bifurcation.

According to the authors, the results of the EBC MAIN suggest starting in the simplest way (provisional stenting); if the results are not as expected, converting to dual stenting is still possible. About 22% of patients randomized to provisional stenting required a second stent after kissing balloon, with no predictive factor detected.

In EBC MAIN, 467 patients —from 11 European countries—with left main coronary artery bifurcation lesion were randomized to provisional stenting (n = 230) vs. systematic dual stenting (n = 237).


Read also: EuroPCR 2021 | TVT Registry: Outcomes of TAVR in Low Surgical Risk Bicuspids.


The double stenting technique was left to operator discretion (culotte, DK crush, minicrush, T/Tap), but proximal optimization and kissing end-balloon were mandatory in both strategies.

Surprisingly enough, the use of intravascular imaging was not mandatory—something that many investigators criticized after the presentation. Another questionable aspect is that there was no experience or volume requirements for centers or operators (despite the fact that their impact has been proven on clinical outcomes and other studies, such as DKCRUSH, factored them in).

EBC-MAIN

Original Title: The European Bifurcation Club Left Main coronary stent study: a randomized comparison of stepwise provisional vs. systematic dual stenting strategies (EBC MAIN).

Reference: Hildick-Smith D et al. Eur Heart Journal. 2021; Epub ahead of print. doi:10.1093/eurheartj/ehab283.


Subscribe to our weekly newsletter

Get the latest scientific articles on interventional cardiology

More articles by this author

Coronary Artery Disease in Aortic Stenosis: CABG + SAVR vs. TAVR + PCI: Data from Spanish Centers

Multiple randomized studies have shown comparable or superior efficacy of transcatheter aortic valve replacement (TAVR) vs. coronary artery bypass graft (CABG).  However, many of...

Evolution of Small Balloon-Expandable Valves

Small aortic rings (20 mm) have posed a significant challenge for both surgery and transcatheter aortic valve implantation (TAVI) due to their association with an...

TCT 2024 | FAVOR III EUROPA

The study FAVOR III EUROPA, a randomized trial, included 2,000 patients with chronic coronary syndrome, or stabilized acute coronary syndrome, and intermediate lesions. 1,008...

TCT 2024 – ECLIPSE: Randomized Study of Orbital Atherectomy vs Conventional PCI in Severely Calcified Lesions

Coronary calcification is associated with stent under-expansion and increased risk of both early and late adverse events. Atherectomy is an essential tool for uncrossable...

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Related Articles

SOLACI Sessionsspot_img

Recent Articles

Severe Tricuspid Regurgitation: Surgical vs. Transcatheter Edge-to-Edge Repair

While highly prevalent, tricuspid regurgitation is a notably undertreated valvulopathy. Its progression has been associated with higher mortality and significant disability. According to the...

ACCESS-TAVI: Comparing Post TAVR Vascular Closure Devices

Transcatheter aortic valve replacement (TAVR) is a well-established option to treat elderly patients with severe symptomatic aortic valve stenosis. Technical advances and device development...

Endovascular Treatment of Iliofemoral Disease for the Improvement of Heart Failure with Preserved Ejection Fraction

Peripheral artery disease (PAD) is a significant risk factor in the development of difficult-to-treat conditions, such as heart failure with preserved ejection fraction (HFpEF)....